Dana Gelbaum has been our Vice President, Global Marketing and Corporate Development since January 2016. Ms. Gelbaum joined us in February 2009 as Director of Business Development. Since 2011 she led pre-commercial planning of octreotide capsules. Prior to joining us, she was Director of Business Development at Recoly N.V., a biotechnology company that is developing product candidates to treat hemophilia A patients. Previously, Ms. Gelbaum was an Associate at Johnson & Johnson Development Corporation (JJDC), Johnson & Johnson’s investment arm, focusing on investments in biopharmaceutical companies in Europe and medical device companies in Israel. Prior to JJDC, she was Associate in Ernst & Young Corporate Finance Life Science Department. Ms. Gelbaum received her M.Sc. and M.B.A. from Tel Aviv University.